Avidity Partners Management LP Ligand Pharmaceuticals Inc Transaction History

Avidity Partners Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$99.52 - $215.83 $6.18 Million - $13.4 Million	-62,100 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$80.55 - $106.05 $5 Million - $6.59 Million	62,100 New	62,100 $6.18 Million
Q2 2020 Aug 14, 2020	SELL	$68.28 - $123.65 $6.96 Million - $12.6 Million	-102,000 Closed	0 $0
Q1 2020 Jun 17, 2020	BUY	$63.37 - $107.88 $6.46 Million - $11 Million	102,000 New	102,000 $7.42 Million

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.